Cancer Market Research Reports & Industry Analysis

Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.

Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.

The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.

Found 1489 publications
Salivary Gland Cancer Global Clinical Trials Review, H1, 2015 US$ 2,500.00

Salivary Gland Cancer Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Salivary Gland Cancer Global Clinical Trials Review, H1, 2015" provides data on the Salivary Gland Cancer clinical trial ...

Mar, 2015 83 pages
Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2015 US$ 2,500.00

Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2015" provides data on the Nonseminomatous Testicular Cancer clinical trial ...

Mar, 2015 66 pages
Global Predictive Breast Cancer Gene Testing Industry 2015 Market Research Report US$ 2,850.00

2015 Global Predictive Breast Cancer Gene Testing Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Predictive Breast Cancer Gene Testing industry ... : 1.) basic information; 2.) the Asia Predictive Breast Cancer Gene Testing industry; 3.) the North American Predictive Breast Cancer Gene Testing industry; 4.) the European Predictive Breast Cancer Gene Testing industry; 5.) market entry and ...

Mar, 2015 172 pages
Global In-vitro Colorectal Cancer Screening Tests Industry 2015 Market Research Report US$ 2,850.00

2015 Global In-vitro Colorectal Cancer Screening Tests Industry Report is a professional and in-depth research report on the world's major regional market conditions of the In-vitro Colorectal Cancer Screening Tests industry ... : 1.) basic information; 2.) the Asia In-vitro Colorectal Cancer Screening Tests industry; 3.) the North American In-vitro Colorectal Cancer Screening Tests industry; 4.) the European In-vitro Colorectal Cancer Screening Tests industry; 5.) market entry and ...

Mar, 2015 172 pages
Global Breast Cancer Imaging Industry 2015 Market Research Report US$ 2,850.00

2015 Global Breast Cancer Imaging Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Breast Cancer Imaging industry, focusing on the ... with: 1.) basic information; 2.) the Asia Breast Cancer Imaging industry; 3.) the North American Breast Cancer Imaging industry; 4.) the European Breast Cancer Imaging industry; 5.) market entry and investment feasibility ...

Mar, 2015 172 pages
Oncology Information System Market by Software (Patient Information System & TPS), & Professional Service), Application (Medical, Radiation, & Surgical Oncology), End User (Hospital,... US$ 4,650.00

... of the oncology information system market in this region. The global oncology information system market is highly competitive, with a large number of global and local players. As of 2013, the global oncology information system market was ... in the oncology information system market Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various oncology information systems across geographies Market Diversification: Exhaustive information

Mar, 2015 173 pages
Cancer Growth Inhibitors Market & Clinical Pipeline Analysis US$ 2,400.00

... Cancer Growth Inhibitors Cancer Growth Inhibitors Clinical Pipeline by Company, Indication & Phase Cancer Growth Inhibitors Clinical Pipeline: 629 Drugs Markets Cancer Growth Inhibitors: 48 Drugs Tyrosine Kinase Dominates Cancer Growth Inhibitors Pipeline: 394 Drugs HDAC Inhibitors Clinical Pipeline: 65 Drugs ...

Apr, 2015 1000 pages
Thymus Carcinoma Global Clinical Trials Review, H1, 2015 US$ 2,500.00

Thymus Carcinoma Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Thymus Carcinoma Global Clinical Trials Review, H1, 2015' provides data on the Thymus Carcinoma clinical trial ...

Feb, 2015 63 pages
Intestinal Cancer Global Clinical Trials Review, H1, 2015 US$ 2,500.00

Intestinal Cancer Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Intestinal Cancer Global Clinical Trials Review, H1, 2015' provides data on the Intestinal Cancer clinical trial ...

Feb, 2015 247 pages
Follicular Thyroid Cancer Global Clinical Trials Review, H1, 2015 US$ 2,500.00

Follicular Thyroid Cancer Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Follicular Thyroid Cancer Global Clinical Trials Review, H1, 2015' provides data on the Follicular Thyroid Cancer clinical trial ...

Feb, 2015 84 pages
Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015 US$ 2,500.00

Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015' provides data on the Extrahepatic Bile Duct Cancer clinical trial ...

Feb, 2015 94 pages
Angiosarcoma Global Clinical Trials Review, H1, 2015 US$ 2,500.00

... Angiosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Angiosarcoma. It includes an overview of the trial numbers and their recruitment ...

Feb, 2015 78 pages
Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015 US$ 2,500.00

Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015' provides data on the Anaplastic Thyroid Cancer clinical trial ...

Feb, 2015 80 pages
Global Cancer Monoclonal Antibody Partnering 2010-2015: Deal Trends, players, financials and forecasts US$ 1,995.00

... cancer monoclonal antibody partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer monoclonal antibody partnering contract documents Top cancer monoclonal antibody deals by value The Global Cancer Monoclonal Antibody Partnering 2010-2015: Deal ...

Mar, 2015 659 pages
Cancer Targeted Therapy Market & Clinical Insight 2015 US$ 3,300.00

... Cancer Targeted Therapy Market & Clinical Insight” Report Highlight: Introduction & Categorization of Cancer Targeted Therapies Mechanism of Cancer Targeted Tyrosine Kinase, Vaccines, Oncogenes Inhibitors, Monoclonal Antibodies Cancer Targeted Therapy ...

Apr, 2015 2900 pages
US Thyroid Cancer Market: Trends and Opportunities (2015 – 2019) US$ 800.00

... “US Thyroid Cancer Market: Trends and Opportunities (2015-2019)” provides an insight into the overall thyroid cancer market of the United States of America. The report analyzes in detail the segments of Thyroid Cancer Market that ... titled “US Thyroid Cancer Market: Trends and Opportunities (2015-2019)” provides an insight into overall thyroid cancer sector of United States of America. The report includes detailed information on market size, installed ...

Apr, 2015 75 pages
Thyroid Cancer-API Insights, 2015 US$ 1,250.00

... Thyroid Cancer. API intelligence over marketed drugs for Thyroid Cancer and gaining primary intelligence over active ingredients manufacturers across the globe. Uncovering opportunities in the rapidly growing the US markets ...

Apr, 2015 60 pages
Testicular Cancer-API Insights, 2015 US$ 1,250.00

... Testicular Cancer. API intelligence over marketed drugs for Testicular Cancer and gaining primary intelligence over active ingredients manufacturers across the globe. Uncovering opportunities in the rapidly growing the US markets ...

Apr, 2015 60 pages
Small-Cell Lung Cancer-API Insights, 2015 US$ 1,250.00

... Small-Cell Lung Cancer-API Insights, 2015,report provides Small-Cell Lung Cancer drugs marketed details and API Manufacturers ...

Apr, 2015 60 pages
Pancreatic Cancer-API Insights, 2015 US$ 1,250.00

... Pancreatic Cancer. API intelligence over marketed drugs for Pancreatic Cancer and gaining primary intelligence over active ingredients manufacturers across the globe. Uncovering opportunities in the rapidly growing the US markets ...

Apr, 2015 60 pages
Metastatic Pancreatic Cancer-API Insights, 2015 US$ 1,250.00

... Metastatic Pancreatic Cancer-API Insights, 2015,report provides Metastatic Pancreatic Cancer drugs marketed details and API Manufacturers ... sales forecasts data for the Metastatic Pancreatic Cancer drugs till 2016. The active pharmaceutical ingredients worldwide market ...

Apr, 2015 60 pages
Metastatic Ovarian Cancer-API Insights, 2015 US$ 1,250.00

... Metastatic Ovarian Cancer-API Insights, 2015,report provides Metastatic Ovarian Cancer drugs marketed details and API Manufacturers ... sales forecasts data for the Metastatic Ovarian Cancer drugs till 2016. The active pharmaceutical ingredients worldwide market ...

Apr, 2015 60 pages
Metastatic Colorectal Cancer-API Insights, 2015 US$ 1,250.00

... Metastatic Colorectal Cancer-API Insights, 2015,report provides Metastatic Colorectal Cancer drugs marketed details and API Manufacturers ... sales forecasts data for the Metastatic Colorectal Cancer drugs till 2016. The active pharmaceutical ingredients worldwide market ...

Apr, 2015 60 pages
Metastatic Breast Cancer-API Insights, 2015 US$ 1,250.00

... Metastatic Breast Cancer-API Insights, 2015,report provides Metastatic Breast Cancer drugs marketed details and API Manufacturers ... sales forecasts data for the Metastatic Breast Cancer drugs till 2016. The active pharmaceutical ingredients worldwide market ...

Apr, 2015 60 pages
Medullary Thyroid Cancer-API Insights, 2015 US$ 1,250.00

... Medullary Thyroid Cancer-API Insights, 2015,report provides Medullary Thyroid Cancer drugs marketed details and API Manufacturers ... sales forecasts data for the Medullary Thyroid Cancer drugs till 2016. The active pharmaceutical ingredients worldwide market ...

Apr, 2015 60 pages
Hormone Refractory Breast Cancer-API Insights, 2015 US$ 1,250.00

... Hormone Refractory Breast Cancer-API Insights, 2015,report provides Hormone Refractory Breast Cancer drugs marketed details and API Manufacturers ...

Apr, 2015 60 pages
Head And Neck Cancer-API Insights, 2015 US$ 1,250.00

... Head And Neck Cancer-API Insights, 2015,report provides Head And Neck Cancer drugs marketed details and API Manufacturers ... sales forecasts data for the Head And Neck Cancer drugs till 2016. The active pharmaceutical ingredients worldwide market ...

Apr, 2015 60 pages
Gastric Cancer-API Insights, 2015 US$ 1,250.00

... Gastric Cancer. API intelligence over marketed drugs for Gastric Cancer and gaining primary intelligence over active ingredients manufacturers across the globe. Uncovering opportunities in the rapidly growing the US markets ...

Apr, 2015 60 pages
Esophageal Cancer-API Insights, 2015 US$ 1,250.00

... Esophageal Cancer. API intelligence over marketed drugs for Esophageal Cancer and gaining primary intelligence over active ingredients manufacturers across the globe. Uncovering opportunities in the rapidly growing the US markets ...

Apr, 2015 60 pages
Colorectal Cancer-API Insights, 2015 US$ 1,250.00

... Colorectal Cancer. API intelligence over marketed drugs for Colorectal Cancer and gaining primary intelligence over active ingredients manufacturers across the globe. Uncovering opportunities in the rapidly growing the US markets ...

Apr, 2015 60 pages
Colon Cancer-API Insights, 2015 US$ 1,250.00

... Colon Cancer. API intelligence over marketed drugs for Colon Cancer and gaining primary intelligence over active ingredients manufacturers across the globe. Uncovering opportunities in the rapidly growing the US markets ...

Apr, 2015 60 pages
Cervical Cancer-API Insights, 2015 US$ 1,250.00

... Cervical Cancer. API intelligence over marketed drugs for Cervical Cancer and gaining primary intelligence over active ingredients manufacturers across the globe. Uncovering opportunities in the rapidly growing the US markets ...

Apr, 2015 60 pages
Bladder Cancer-API Insights, 2015 US$ 1,250.00

... Bladder Cancer. API intelligence over marketed drugs for Bladder Cancer and gaining primary intelligence over active ingredients manufacturers across the globe. Uncovering opportunities in the rapidly growing the US markets ...

Apr, 2015 60 pages
PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023 US$ 10,995.00

PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023 Summary Breast cancer is the second most common cancer in the world and the most common cancer ... segments HER2 negative breast cancer into its two major subtypes; hormone receptor positive (HR+) and triple negative breast cancer (TNBC). HR+ disease accounts for around 90% of all HER2 negative breast cancers. It responds ...

Jan, 2015 360 pages
Global & USA Cancer Immunotherapy Market Analysis to 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen... US$ 3,400.00

Global & USA Cancer Immunotherapy Market Analysis to 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell ... KellySciPub’s latest cutting-edge analysis of the Global & USA Cancer Immunotherapy Market Analysis to 2020” reveals that the cancer immunotherapy space will be a significant revenue generator (excess ...

Apr, 2015 256 pages
Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics US$ 4,995.00

Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset ... , “Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics”, which provides in-depth analysis of the Colorectal Cancer (CRC) therapeutics ...

Jan, 2015 104 pages
HER-2 Positive Breast Cancer Market in the US 2015-2019 US$ 3,000.00

... of cancer cases and led to 522,000 deaths worldwide. HER-2 positive breast cancer accounts for almost 25 percent of all types of breast cancer. TechNavio's analysts forecast the HER-2 Positive Breast Cancer market in US to grow ... management of HER-2 positive breast cancer patients. The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the HER-2 Positive Breast Cancer market in the ...

Mar, 2015 108 pages
Global Small Cell Lung Cancer Therapeutics Market 2015-2019 US$ 3,000.00

... rate. There are no therapies available to cure small cell lung cancer in the market. TechNavio's analysts forecast the Global Small Cell Lung Cancer Therapeutics market to grow at a CAGR of 3.60 percent over the period 2014-2019. Covered in this Report TechNavio's report, Global Small Cell Lung Cancer Therapeutics ...

Mar, 2015 102 pages
PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2023 US$ 10,995.00

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2023 SUMMARY Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world ... forecast period. SCOPE Overview of colorectal cancer, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and disease management. Annualized Colorectal cancer therapeutics market revenue, annual ...

Nov, 2014 346 pages
Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation US$ 6,995.00

Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation Summary Large and Diverse Pipeline The liver cancer pipeline contains 238 products in active development ... improve the relatively open liver cancer market. Alignment of First-in-Class Molecular Targets with Disease Causation The liver cancer pipeline is showing signs of adapting ...

Dec, 2014 79 pages
Anal Cancer - Pipeline Review, H1 2015 US$ 2,000.00

Anal Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Anal Cancer - Pipeline Review, H1 2015’, provides an overview of the Anal Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Anal Cancer ...

Feb, 2015 58 pages
Acute Lymphoblastic Lymphoma - Pipeline Review, H1 2015 US$ 2,000.00

Acute Lymphoblastic Lymphoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Acute Lymphoblastic Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Acute Lymphoblastic Lymphoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development ...

Feb, 2015 40 pages
Non-Small Cell Lung Cancer Partnering 2010-2015 US$ 795.00

... non-small cell lung cancer partnering deals Top non-small cell lung cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Non-Small Cell Lung Cancer Partnering 2010-2015 provides understanding and access to the non-small cell lung cancer partnering deals ...

Mar, 2015 150 pages
Non-Hodgkin Lymphoma Partnering 2010-2015 US$ 795.00

... non-hodgkin lymphoma partnering deals Top non-hodgkin lymphoma deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Non-Hodgkin Lymphoma Partnering 2010-2015 provides understanding and access to the non-hodgkin lymphoma partnering deals ...

Mar, 2015 150 pages
Snapshot on Oncology Medicine Market in India - 2015; Market size, Market trends, Growth drivers, Future forecast, Market opportunity US$ 2,000.00

... into the Oncology Medicine current market scenario, structure and practices in India. In depth market scenario includes: Market estimate of Oncology Medicine in India for FY14 Geographical presence of key players in India Providing insights into Industry drivers and challenges and their impact on the future market ...

Mar, 2015 30 pages
Global HER-2 Positive Breast Cancer Market 2015-2019 US$ 3,000.00

... of cancer cases and led to 522,000 deaths worldwide. HER-2 positive breast cancer accounts for almost 25 percent of all types of breast cancer. TechNavio's analysts forecast the Global HER-2 Positive Breast Cancer market ... management of HER-2 positive breast cancer patients. The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global HER-2 Positive Breast Cancer market ...

Mar, 2015 123 pages
Cancer Nanomedicine Market & Pipeline Insight 2015 US$ 2,000.00

... cancer therapy can be achieved. “Cancer Nanomedicine Market & Pipeline Insight 2015” Report Highlight Nanomedicine for Cancer Therapies Cancer Nanoparticles Drug Delivery Systems Classification Mechanism of Cancer Nanomedicine Therapy Cancer Nanomedicine Clinical Pipeline Overview Cancer Nanomedicine ...

Feb, 2015 220 pages
Paraganglioma (Glomus Jugulare Tumor) - Pipeline Review, H1 2015 US$ 2,000.00

... Paraganglioma (Glomus Jugulare Tumor) - Pipeline Review, H1 2015’, provides an overview of the Paraganglioma (Glomus Jugulare Tumor)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Paraganglioma (Glomus Jugulare Tumor ...

Jan, 2015 54 pages
Leiomyosarcoma - Pipeline Review, H1 2015 US$ 2,000.00

... Leiomyosarcoma - Pipeline Review, H1 2015’, provides an overview of the Leiomyosarcoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Leiomyosarcoma, complete with comparative analysis at various stages, therapeutics assessment ...

Jan, 2015 86 pages
Follicular Thyroid Cancer - Pipeline Review, H1 2015 US$ 2,000.00

... Thyroid Cancer - Pipeline Review, H1 2015’, provides an overview of the Follicular Thyroid Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Follicular Thyroid Cancer, complete with comparative analysis at various stages, therapeutics assessment ...

Jan, 2015 73 pages
1 2 3 4 5 >
Skip to top